Breaking News Instant updates and real-time market news.

FB

Facebook

$150.42

6.21 (4.31%)

, BABA

Alibaba

$166.80

9.91 (6.32%)

08:55
01/31/19
01/31
08:55
01/31/19
08:55

Notable open interest changes for January 31st

Wednesday's total option volume of 21.8 million contracts resulted in net open interest growth of 3.35 million calls and 3.63 million puts. Facebook (FB), Alibaba (BABA), General Electric (GE) and Microsoft (MSFT) saw the greatest growth. Top five new positions opened include 34k General Electric (GE) 2/1 weekly 8 puts, 23k Intel (INTC) 3/1 weekly 48 calls, 17k Microsoft (MSFT) Feb-19 115 calls, 17k Facebook (FB) 2/1 weekly 155 calls and 16k Plains All American (PAA) Feb-19 24.5 calls.

FB

Facebook

$150.42

6.21 (4.31%)

BABA

Alibaba

$166.80

9.91 (6.32%)

GE

General Electric

$9.10

0.2 (2.25%)

MSFT

Microsoft

$106.34

3.41 (3.31%)

  • 31

    Jan

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

FB Facebook
$150.42

6.21 (4.31%)

01/31/19
OPCO
01/31/19
NO CHANGE
Target $195
OPCO
Outperform
Facebook price target raised to $195 from $185 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price for Facebook to $195 from $185 following quarterly results, while reiterating an Outperform rating on the shares. The analyst notes that usage trends remain solid, suggesting minimal impact from negative news coverage.
01/31/19
COWN
01/31/19
NO CHANGE
Target $195
COWN
Outperform
Facebook price target raised to $195 from $184 at Cowen
Cowen analyst John Blackledge raised his target on Facebook to $195 from $184 and raised his estimates following Q4 results. The analyst cited its revenue guidance, solid ad revenues, and good user growth. Blackledge reiterated his Outperform rating on Facebook shares.
01/31/19
MSCO
01/31/19
NO CHANGE
Target $190
MSCO
Overweight
Facebook 'story starting to get good,' says Morgan Stanley
Morgan Stanley analyst Brian Nowak stated in a research note partially titled "This Story Is Starting to Get Good" that Facebook's strong finish to 2018 speaks to the strength of its engagement, ad offering and ability to drive earnings power even in the face of public scrutiny and aggressive investment. The analyst, who called the "green shoots" he sees in Stories monetization and engagement "particularly positive," raised his price target on Facebook shares to $190 from $175 and keeps an Overweight rating on the stock.
01/31/19
WELS
01/31/19
NO CHANGE
Target $200
WELS
Outperform
Facebook's Q4 'hits the mark,' says Wells Fargo
Wells Fargo analyst Robert Coolbrith notes Facebook reported a "solid" Q4. While monetization crosswinds persist, investment levels should remain elevated in the near-term, and headline risk remains a key factor, the analyst continues to expect fundamentals to stabilize, headline risk to gradually recede and investor sentiment to turn more positive over the course of 2019. Coolbrith reiterates nr Outperform rating and $200 price target on the shares.
BABA Alibaba
$166.80

9.91 (6.32%)

01/30/19
BARD
01/30/19
NO CHANGE
Target $178
BARD
Outperform
Alibaba long-term thesis intact after 'solid' results, says Baird
Baird analyst Colin Sebastian says the long-term thesis on Alibaba Group shares is intact after the company this morning reported "solid" results despite macro pressures. Alibaba posted a slight sales miss with a profitability beat, as core commerce margins offset elevated investments in local services, Lazada, and New Retail, Sebastian tells investors in a post-earnings research note. The analyst finds it important that management suggested only a limited impact from China macro issues on Alibaba's core verticals. Further, a more constructive government policy in the form of higher VAT exemption thresholds should provide additional support to merchants, Sebastian contends. He keeps an Outperform rating on Alibaba shares with a $178 price target. The stock in midday trading is up 4%, or $7.02, to $163.90.
01/30/19
JPMS
01/30/19
NO CHANGE
JPMS
Overweight
JPMorgan more positive on Alibaba earnings growth outlook
JPMorgan analyst Alex Yao says he's turning more positive on Alibaba's earnings growth outlook following this morning's fiscal Q3 results. The analyst sees the company's advertising revenue growing to 32% year-over-year in the March quarter driven by traffic, engagement and search algorithm optimization. The acceleration of "highly profitable" ads revenue should lead to faster earnings growth, Yao tells investors in a post-earnings research note. He recommends investors own Alibaba given the resilience of its core commerce growth outlook.
01/31/19
OPCO
01/31/19
NO CHANGE
Target $195
OPCO
Outperform
Alibaba price target raised to $195 from $185 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Alibaba to $195 from $185 on strong Q3 core commerce results. The analyst reiterates an Outperform rating on the shares.
01/31/19
RHCO
01/31/19
NO CHANGE
Target $200
RHCO
Buy
Alibaba price target raised to $200 from $180 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Alibaba to $200 and kept his Buy rating after its Q3 earnings beat, saying the company has executed in spite of the "increasingly challenging macro economic/political backdrop". The analyst adds that Alibaba's secular growth drivers of rising China consumption, healthy household balance sheets, and retail digitization remain intact, even though he is a bit more cautious about the macro uncertainty, regulatory tightening, and the management's "decision to postpone monetization of new recommendation feed ".
GE General Electric
$9.10

0.2 (2.25%)

01/25/19
GDHS
01/25/19
NO CHANGE
Target $7
GDHS
Underperform
GE modification of Wabtec deal reflects 'need for cash,' says Gordon Haskett
Gordon Haskett analyst John Inch noted that Wabtec (WAB) and General Electric (GE) announced a modification to their rail merger agreement, calling it "unusual" for the terms of such a merger to be "changed in the 11th hour." The modified deal does not appear to be beneficial to GE shareholders and GE stated that the modification is to strengthen the company's balance sheet, which reinforces Inch's view that GE is "desperate for cash to pay down its debt and other liabilities as quickly as possible," he tells investors. Inch has an Underperform rating and $7 price target on GE shares.
01/28/19
JPMS
01/28/19
NO CHANGE
JPMS
Neutral
GE news Friday 'couple of steps backward on a few fronts,' says JPMorgan
JPMorgan analyst Stephen Tusa says that despite a stock reaction that suggested progress, he views General Electric's news flow from Friday in total as a "couple of steps backward on a few fronts for the GE shareholder." First, the GE story "is about a transfer of asset value away from the equity holder-more of a salvage situation than about equity value creation, a progression that we believe is now well under way," Tusa tells investors in a research note. He thinks shareholders will be left with a run rate on earnings and cash flow that is "well below an expectation that remains too optimistic." GE stock was never priced for a liquidity situation, and while drawing down bank lines and making moves to bring cash suggest there is an eye toward liquidity, this remains more about what is left when the dust settles as the company drives towards a more sustainable capital structure, says Tusa. He keeps a Neutral rating on shares of General Electric.
01/28/19
GDHS
01/28/19
NO CHANGE
Target $7
GDHS
Underperform
GE could shift to GAAP accounting, causing stock drop, says Gordon Haskett
New General Electric (GE) CEO Larry Culp likely has every intention of establishing a 2019 guidance framework that the company can actually achieve, which would be welcomed by investors after years of "non-credible GE guidance, perpetual exaggerations, opaque disclosure and aggressive accounting," Gordon Haskett analyst John Inch told investors earlier in a research note titled "Move to GAAP could drive stock hit." The analyst has an Underperform rating on General Electric with a $7 price target. The stock in morning trading is down 33c to $8.83. He believes Larry Culp, in contrast with previous CEO John Flannery, is going to want to set a guidance bar that GE "can at least hit." In turn, while GE may not be able to adopt more conservative accounting while under government investigation, a move to GAAP would at least demonstrate Culp's directional willingness to abandon the "inflated and exaggerated earnings presentation practices of the past," says Inch. However, if GE were to move to GAAP accounting, its share price would move lower, driven by a lower GAAP impact on consensus, the analyst contends. Further, GE's accounting could still be viewed as aggressive under a GAAP presentation framework, adds Inch. As such, he thinks subsequent future restatements from the adoption of more conservative accounting "could readily ensue." Inch also sees risks in GE's revised deal with Wabtec deal (WAB).
01/29/19
JPMS
01/29/19
NO CHANGE
JPMS
Neutral
General Electric risk/reward unfavorable ahead of earnings, says JPMorgan
JPMorgan analyst Stephen Tusa sees an unfavorable risk/reward for General Electric shares ahead of the company's Q4 earnings report on Thursday, as he expects investors' focus to be on "hard data around run rate fundamentals," including near-term free cash flow, as well as any update on strategic de-leveraging plans and the associated dilutive impact. His base case is that tangible news, both on fundamentals and portfolio moves, will support his "well below-consensus" view. Tusa thinks the recent stock move is built upon an expectation of more certainty in the path forward, which investors may or may not get, but if even if they get it the details will highlight potential equity holder dilution, he stated in an earnings preview note. Tusa. He keeps a Neutral rating on GE.
MSFT Microsoft
$106.34

3.41 (3.31%)

01/31/19
ADAM
01/31/19
NO CHANGE
Target $120
ADAM
Buy
Microsoft weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Davis said he would buy the dip in Microsoft shares and keeps it as a core holding. The analyst felt expectations coming into the print were high, but he said his thesis remains both simple and unchanged. He sees its growth drivers accelerating with upwardly inflecting margins and believes that the biggest risk to the company is stock market based. Davis reiterated his Buy rating and $120 price target on Microsoft shares.
01/31/19
BERN
01/31/19
NO CHANGE
BERN
Microsoft near-term headwinds mask continued cloud momentum, says Bernstein
Bernstein analyst Mark Moerdler notes that Microsoft reported Q2 FY19 results after the market close on Wednesday, with a relatively in-line quarter as Cloud strength was hindered by weakness in Windows and Consumer Office. The analyst notes that comparisons become harder in H2 for the transactional businesses, along with continued PC chip supply chain issues could lead to continued near-term headwinds.
01/31/19
UBSW
01/31/19
NO CHANGE
Target $125
UBSW
Buy
Microsoft Q2 results should provide relief for shares, says UBS
UBS analyst Jennifer Swanson Lowe said Microsoft delivered strong Q2 results with only a slight drag on earnings from demand woes plaguing other parts of the HW supply chain. The analyst believes the results will provide some relief for the shares. She sees Cloud as the key driver for the stock's multiple, as well as the company's revenue and profits. Lowe reiterated her Buy rating and $125 price target on Microsoft shares.
01/31/19
OPCO
01/31/19
NO CHANGE
Target $127
OPCO
Outperform
Microsoft's cloud driving operating leverage, says Oppenheimer
Following Microsoft's quarterly results, Oppenheimer analyst Timothy Horan says hybrid demand is driving growth for Microsoft cloud-based enterprise solutions, with IT spending holding up despite macro concerns. Microsoft is building its intelligent hybrid cloud/edge platform to span all its businesses, which is enabling unique integrations and margin expansion, he contends. The analyst believes Microsoft is well positioned as gaming moves over-the-top due to its content and Azure infrastructure. Overall, Microsoft is seeing strong demand in its commercial business as enterprises digitalize-LinkedIn, Dynamics. Weakness in consumer was largely attributed to limited PC supply, he argues. Horan reiterates an Outperform rating and $127 price target on the shares.

TODAY'S FREE FLY STORIES

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.